Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05289544
Other study ID # Pro00115106
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 1, 2022
Est. completion date September 29, 2024

Study information

Verified date October 2023
Source University of South Carolina
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study is to examine the short-term (6-weeks and 6 months) and long-term (1 year) effects of a phone-based version of Walk With Ease intervention.


Description:

Participants will be randomized to either start the 6-week program immediately or after one year. Our Walk with Ease by Telephone (WWE-T) program is adapted from the original 6-week community-based group walking program developed by the Arthritis Foundation for adults with arthritis. The phone-based program will include 2 phone calls each week with a trained Walk With Ease Leader for 6 weeks. Assessments will be completed before at the start of the study, 6 weeks, 6 months and at 12 months.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 300
Est. completion date September 29, 2024
Est. primary completion date September 29, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, gout, lupus, fibromyalgia - able to read and write in English - plan to live in the Columbia, SC region for next year - willing to be randomized to either group - complete all baseline measure Exclusion Criteria: - contraindications to exercise (besides arthritis) - are pregnant, breastfeeding, or planning to become pregnant in the next year - have a serious cognitive impairment

Study Design


Intervention

Behavioral:
Phone-Based Walk With Ease
6 week phone-delivered Walk With Ease Program

Locations

Country Name City State
United States University of South Carolina Columbia South Carolina

Sponsors (2)

Lead Sponsor Collaborator
University of South Carolina Centers for Disease Control and Prevention

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in pain Visual analog scale (100 mm) Baseline to 6 weeks
Primary Change in pain Visual analog scale (100 mm) Baseline to 6 months
Primary Change in pain Visual analog scale (100 mm) Baseline to 12 months
Primary Change in physical function - chair stands repetitions completed during 30 second chair stand test Baseline to 6 weeks
Primary Change in physical function - chair stands repetitions completed during 30 second chair stand test Baseline to 6 months
Primary Change in physical function - chair stands repetitions completed during 30 second chair stand test Baseline to 12 months
Primary Change in physical function - 6 minute walk Distance walked (ft) during 6 minute walk test Baseline to 6 weeks
Primary Change in physical function - 6 minute walk Distance walked (ft) during 6 minute walk test Baseline to 6 months
Primary Change in physical function - 6 minute walk Distance walked (ft) during 6 minute walk test Baseline to 12 months
Secondary Change in Physical Limitations Health Assessment Questionnaire (HAQ) - Total score ranging from 0-3, with a higher score indicating more impairment or disability Baseline to 6 weeks
Secondary Change in Physical Limitations Health Assessment Questionnaire (HAQ) - Total score ranging from 0-3, with a higher score indicating more impairment or disability Baseline to 6 months
Secondary Change in Physical Limitations Health Assessment Questionnaire (HAQ) - Total score ranging from 0-3, with a higher score indicating more impairment or disability Baseline to 12 months
Secondary Change in physical activity total moderate and vigorous intensity physical activity (>=2020 cpm) measured by Actigraph GT3x Link activity monitors Baseline to 6 weeks
Secondary Change in physical activity total moderate and vigorous intensity physical activity (>=2020 cpm) measured by Actigraph GT3x Link activity monitors Baseline to 6 months
Secondary Change in physical activity total moderate and vigorous intensity physical activity (>=2020 cpm) measured by Actigraph GT3x Link activity monitors Baseline to 12 months
Secondary Change in arthritis management self-efficacy Confidence to manage symptoms of arthritis assessed by the Arthritis Self-Efficacy Scale. Total score 0-10 with higher scores indicating higher levels of self-efficacy for managing arthritis Baseline to 6 weeks
Secondary Change in arthritis management self-efficacy Confidence to manage symptoms of arthritis assessed by the Arthritis Self-Efficacy Scale. Total score 0-10 with higher scores indicating higher levels of self-efficacy for managing arthritis Baseline to 6 months
Secondary Change in arthritis management self-efficacy Confidence to manage symptoms of arthritis assessed by the Arthritis Self-Efficacy Scale. Total score 0-10 with higher scores indicating higher levels of self-efficacy for managing arthritis Baseline to 12 months
Secondary Change in blood pressure Diastolic and systolic blood pressure measured in mmHg Baseline to 6 weeks
Secondary Change in blood pressure Diastolic and systolic blood pressure measured in mmHg Baseline to 6 months
Secondary Change in blood pressure Diastolic and systolic blood pressure measured in mmHg Baseline to 12 months
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis or Systemic Lupus Erythematosus Phase 1
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4

External Links